ATYR
aTyr Pharma, Inc.
0.3564$
-4.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +528.1% | -37.9% | +11.0% | -41.0% | -31.4% | +7.0% | +198.3% | -17.1% | +26.0% | -19.7% | -2.8% | |
| – | +493.3% | -23.7% | +16.3% | -41.6% | -37.2% | +11.3% | +219.6% | -28.8% | +27.4% | -20.4% | -2.1% | |
| – | +281.5% | -27.6% | -45.1% | +8.9% | -59.9% | +84.1% | -86.2% | +327.3% | +125.9% | -51.0% | -2.8% | |
| – | +502.6% | -24.5% | +18.0% | -41.8% | -37.1% | +1.7% | +240.5% | -38.7% | +48.4% | -26.5% | +9.1% | |
| – | – | – | – | – | – | +1,939.0% | -78.7% | +2,606.9% | -79.3% | -28.7% | -49.7% | |
| – | -86.9% | +21.2% | +41.7% | -24.0% | -20.6% | -52.2% | -11.5% | +282.2% | +23.2% | -10.6% | -0.5% | |
| – | +20.1% | -29.8% | +21.9% | +4.3% | +19.3% | -54.6% | +2.5% | +130.5% | +18.4% | -8.8% | +1.2% | |
| – | -34.4% | -89.9% | +1,378.5% | +55.0% | +22.2% | -90.9% | +13.8% | -8.8% | +48.5% | -5.7% | +17.1% | |
| – | +170.2% | -32.7% | -12.7% | -54.3% | -18.6% | +68.9% | -28.0% | +201.3% | +13.6% | +22.5% | -10.0% | |
| – | – | -45.4% | +2.3% | -47.6% | -37.0% | +49.4% | +245.3% | -34.6% | +26.9% | -22.8% | -3.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,798.6% | +49.5% | +8.9% | +16.1% | +56.8% | +173.0% | +108.3% | +48.9% | +88.6% | +38.5% | +25.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.